OLYMPIA - Gov. Chris Gregoire today congratulated the Life
Sciences Discovery Fund Board of Trustees on the
appointment of John DesRosier, Ph.D. as executive director
of the Fund. Effective July 2, DesRosier, who is currently
director of programs at LSDF, will succeed founding
executive director Lee Huntsman, Ph.D. who announced his
retirement effective June 30.
"Our Life Sciences sector has led to new jobs and cutting
edge research for which we are known the world over,"
Gregoire said. "Since 2006, John has been a part of the
success and I'm delighted he has accepted the role of
executive director, and am confident that he will continue
Lee's legacy of exceptional leadership and stewardship of
the state's investment."
"I am excited to take the reins at LSDF, and I thank
Governor Gregoire, Lee, and the Life Sciences Discovery
Fund Board of Trustees for their confidence in me. It is an
honor to be following in the footsteps of my mentor,"
DesRosier said. "I look forward to my expanded role at
LSDF, working with our talented and dedicated staff to
develop and execute initiatives to move research
discoveries out of the lab to benefit both human health and
the economy in our state."
The Life Sciences Discovery Fund was established in 2005 by
Gov. Gregoire and the Washington State Legislature. Funded
by monies from the Master Tobacco Settlement Agreement of
1998, the program issues research grants statewide in
support of Washington's growing life sciences sector-
improving the health and economic wellbeing of Washington
"I leave LSDF with the certainty that the organization will
continue to meet its mission in John's supremely capable
and accomplished hands," said founding executive director
"John's successes at LSDF, his many contacts around the
state, and his years of experience in technology
commercialization and economic development make him the
ideal choice to lead the organization," said Chris Rivera,
president of the Washington Biotechnology & Biomedical
Before joining LSDF, DesRosier spent six years as a
technology commercialization consultant, specializing in
the transfer of academic research innovations from
nonprofits to the industrial sector. He also worked at the
University of Washington for eleven years, where he was
responsible for commercialization of biomedical
technologies and a liaison to industry. DesRosier brings
more than 30 years of research and technology
commercialization experience to his new role.
DesRosier received his Ph.D. in microbiology from the
University of Washington. He went on to work at Ohio
Wesleyan University and Middlebury College before joining
BioControl Systems in Bothell, Washington where he was part
of a team that launched four diagnostic products for
detecting pathogenic bacteria in foods.